申请人:Pfizer Inc.
公开号:US05300668A1
公开(公告)日:1994-04-05
1-[4'-(2"-Ethyl-5",7"-dimethylimidazo[4,5-b]pyridin-3-yl)methylphenyl]cyclo pent-3-ene-1-carboxylic acid and its pharmaceutically acceptable salts inhibit angiotensin II in mammals and are useful in treating conditions such as hypertension, congestive heart failure and glaucoma and as the active ingredient in pharmaceutical compositions for treating such conditions.
1-[4'-(2"-乙基-5",7"-二甲基咪唑[4,5-b]吡啶-3-基)甲基苯基]环戊-3-烯-1-羧酸及其药学上可接受的盐可以抑制哺乳动物中的血管紧张素II,适用于治疗高血压、充血性心力衰竭和青光眼等疾病,并作为药物组成部分用于治疗此类疾病。